Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
1,148,777,709
-
Total 13F shares
-
553,974,646
-
Share change
-
-46,593,417
-
Total reported value
-
$4,971,872,721
-
Put/Call ratio
-
164%
-
Price per share
-
$8.98
-
Number of holders
-
430
-
Value change
-
-$440,161,645
-
Number of buys
-
218
-
Number of sells
-
165
Institutional Holders of Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q1 2020
As of 31 Mar 2020,
Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
430 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
553,974,646 shares.
The largest 10 holders included
Capital Research Global Investors, Berkshire Hathaway Inc, BlackRock Inc., Capital World Investors, ABRAMS CAPITAL MANAGEMENT, L.P., Migdal Insurance & Financial Holdings Ltd., MENORA MIVTACHIM HOLDINGS LTD., STATE STREET CORP, Capital International Investors, and Clal Insurance Enterprises Holdings Ltd.
This page lists
430
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.